| abstract |
The present invention provides a pharmaceutical composition having alpha 4 integrin mediated cell adhesion inhibitory activity. As an active ingredient, the following formula (I): [Chemical 1] (I) A pharmaceutical composition comprising a novel phenylalanine compound having an α 4 integrin-mediated cell adhesion inhibitory activity or a pharmacologically acceptable derivative thereof as an active ingredient. [Selection figure] None |